Trials / Completed
CompletedNCT06180876
Effect of Remimazolam on Postoperative Delirium
Effect of General Anesthesia With Remimazolam Versus Propofol on Postoperative Delirium in Elderly Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 264 (actual)
- Sponsor
- Zhihong LU · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Remimazolam is a novel benzodiazepine with ultra-short onset and offset of its effect. It can be used for general anesthesia. However, classical benzodiazepine such as midazolam was reported to increase the risk of postoperative delirium. Thus, the investigators aim to investigate the effect of remimazolam general anesthesia on postoperative delirium in elderly patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | remimazolam | continuous infusion |
| DRUG | propofol | continuous infusion |
Timeline
- Start date
- 2022-07-25
- Primary completion
- 2024-01-25
- Completion
- 2024-01-30
- First posted
- 2023-12-26
- Last updated
- 2026-02-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06180876. Inclusion in this directory is not an endorsement.